Please login to the form below

Not currently logged in
Email:
Password:

Oscar Ferenczi joins Grünenthal from Sandoz

Will lead German pharma company's Latin American expansion plans

Grünenthal has appointed former region head of Sandoz Latin America Oscar Ferenczi to lead its own Latin America business.

Ferenczi will assume the role of executive VP for Grünenthal Latin America and will also take over as general manger Grünenthal Panama, where the company's regional head office is, and as general manager Grünenthal Latin America, Miami.

He will be based in Miami, Florida, and will report directly to Grünenthal's CEO Dr Harald Stock.

The appointment is a signal of intent for the German pharma company's plans to expand in the emerging Latin America market, which has included the acquisition of Brazilian firm Selfarma and an agreement with US-based Horizon Pharma for the commercialisation of the anti-inflammatory drug Duexis in Latin America.

Ferenczi has years of experience in the market, including nearly four years in his position at Sandoz.

Prior to this period, he spent more than at decade at Merck & Co in the region, including spells as general manager Ecuador, general manager Peru, general manager Chile, and VP and general manager Brazil.

“Strengthening our businesses in Latin America is one of our core strategic objectives as we are aiming to generate 40 percent of Grünenthal's commercial business from the region in 2015,” said CEO Stock.

“I am glad that Oscar has decided to lead the group's strategic business unit with its ambitious, dedicated, and passionate people."

20th February 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics